StayCurrentMD · Intercostal Nerve Cryoablation in Minimally Invasive Repair of Pectus Excavatum: National Trends, Outcomes, and Predictors of Utilization
Article1 min read·Published Nov 2024

Intercostal Nerve Cryoablation in Minimally Invasive Repair of Pectus Excavatum: National Trends, Outcomes, and Predictors of Utilization

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Nov 2024 · 1 min read

In brief

In brief

This study examines national adoption patterns of intercostal nerve cryoablation as an adjunct pain control method during minimally invasive pectus excavatum repair (MIRPE/Nuss procedure). The analysis evaluates clinical outcomes and identifies factors influencing surgeon utilization of this technique amid ongoing insurance reimbursement controversies.

  • Intercostal nerve cryoablation is an effective pain control technique during MIRPE but faces reimbursement challenges from insurers.
  • Some insurers classify cryoablation as experimental, limiting coverage despite clinical evidence of efficacy.
  • National utilization patterns vary, suggesting inconsistent adoption across institutions and regions.
  • Understanding predictors of cryoablation use can inform standardization and reimbursement advocacy efforts.
  • Outcomes data support cryoablation's role in multimodal pain management for pectus excavatum repair.

Written by the GCMD Library team from the article.

Intercostal nerve cryoablation during minimally invasive repair of pectus excavatum (MIRPE) is an effective pain control technique. Some insurers may not reimburse for cryoablation in this context, contending that it’s an experimental procedure. This study aimed to describe national trends in cryoablation use and evaluate outcomes and predictors of its use.

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →